{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:23:47Z","timestamp":1775125427256,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.03.076","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T19:11:58Z","timestamp":1523905918000},"page":"2816-2824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias"],"prefix":"10.1016","volume":"36","author":[{"given":"Erika","family":"Garner-Spitzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Seidl-Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zwazl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Kinaciyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhart","family":"Jarisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Stiasny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard J.","family":"Zlabinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Wiedermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.03.076_b0005","unstructured":"WAO. World Allergy Association - White Book on Allergy 2012."},{"issue":"7203","key":"10.1016\/j.vaccine.2018.03.076_b0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2018.03.076_b0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.03.076_b0020","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1542\/peds.2006-3569","article-title":"Is childhood vaccination associated with asthma? A meta-analysis of observational studies","volume":"120","author":"Balicer","year":"2007","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2018.03.076_b0025","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.vaccine.2005.10.056","article-title":"Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8\u201312-year-old children","volume":"24","author":"Bernsen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.076_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","author":"Nilsson","year":"2017","journal-title":"Pediatric Allergy Immunol: Off Publ Eur Soc Pediatric Allergy Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.076_b0035","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/pai.12391","article-title":"Asthma and allergy in children with and without prior measles, mumps, and rubella vaccination","volume":"26","author":"Timmermann","year":"2015","journal-title":"Pediatric Allergy Immunol: Off Publ Eur Soc Pediatric Allergy Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.076_b0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1399-3038.2005.00331.x","article-title":"Antibody levels to Bordetella pertussis in 10-yr-old children with atopy and atopic asthma","volume":"16","author":"Blanco-Quiros","year":"2005","journal-title":"Pediatric Allergy Immunol: Off Publ Eur Soc Pediatric Allergy Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.03.076_b0045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2012.12.075","article-title":"Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination","volume":"31","author":"Paulke-Korinek","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.03.076_b0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.03.076_b0055","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.1300293","article-title":"Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10","volume":"191","author":"Garner-Spitzer","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.03.076_b0060","first-page":"10","article-title":"Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application","volume":"47","author":"Ullrich","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"Suppl 82","key":"10.1016\/j.vaccine.2018.03.076_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2006.01219_1.x","article-title":"Standards for practical allergen-specific immunotherapy","volume":"61","author":"Alvarez-Cuesta","year":"2006","journal-title":"Allergy"},{"issue":"13","key":"10.1016\/j.vaccine.2018.03.076_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2807\/1560-7917.ES2015.20.13.21077","article-title":"Emergence of tick-borne encephalitis in new endemic areas in Austria: 42 years of surveillance","volume":"20","author":"Heinz","year":"2015","journal-title":"Euro Surveill"},{"issue":"19","key":"10.1016\/j.vaccine.2018.03.076_b0075","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.03.076_b0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.076_b0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18\u201367 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Human Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2018.03.076_b0090","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.2741\/3139","article-title":"T cell responses during allergen-specific immunotherapy of Type I allergy","volume":"1","author":"Bohle","year":"2008","journal-title":"Front Biosci: J Virtual Library"},{"issue":"9","key":"10.1016\/j.vaccine.2018.03.076_b0095","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1365-2222.2011.03812.x","article-title":"Mechanisms of immunotherapy to wasp and bee venom","volume":"41","author":"Ozdemir","year":"2011","journal-title":"Clin Exp Allergy: J British Soc Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.03.076_b0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s150100050051","article-title":"Laboratory findings in tick-borne encephalitis\u2013correlation with clinical outcome","volume":"28","author":"Kaiser","year":"2000","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.vaccine.2018.03.076_b0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-9071(199703)51:3<242::AID-JMV17>3.0.CO;2-M","article-title":"Avidity determination of IgG directed against tick-borne encephalitis virus improves detection of current infections","volume":"51","author":"Gassmann","year":"1997","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.076_b0110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1399-3038.2010.01025.x","article-title":"Correlation of allergen-specific IgG subclass antibodies and T lymphocyte cytokine responses in children with multiple food allergies","volume":"21","author":"Scott-Taylor","year":"2010","journal-title":"Pediatric Allergy Immunol: Off Publ Eur Soc Pediatric Allergy Immunol"},{"key":"10.1016\/j.vaccine.2018.03.076_b0115","doi-asserted-by":"crossref","first-page":"236075","DOI":"10.1155\/2012\/236075","article-title":"The contribution of allergen-specific IgG to the development of th2-mediated airway inflammation","volume":"2012","author":"Williams","year":"2012","journal-title":"J Allergy"},{"issue":"5","key":"10.1016\/j.vaccine.2018.03.076_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.10.022","article-title":"Monitoring the epitope recognition profiles of IgE, IgG1, and IgG4 during birch pollen immunotherapy","volume":"137","author":"Gepp","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.076_b0125","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"44","key":"10.1016\/j.vaccine.2018.03.076_b0130","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2018.03.076_b0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2012.00302","article-title":"Advances in human B cell phenotypic profiling","volume":"3","author":"Kaminski","year":"2012","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2018.03.076_b0140","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.vaccine.2018.03.076_b0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/CRIAI:29:1:061","article-title":"Anti-CD23","volume":"29","author":"Rosenwasser","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2 Suppl 2","key":"10.1016\/j.vaccine.2018.03.076_b0150","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.03.076_b0155","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2394","article-title":"The X-files in immunity: sex-based differences predispose immune responses","volume":"8","author":"Fish","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.03.076_b0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.03.076_b0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.03.076_b0170","first-page":"626","article-title":"Distribution of virus antibody activity among human IgG subclasses","volume":"43","author":"Beck","year":"1981","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.03.076_b0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-0934(89)90028-1","article-title":"Properties of IgG subclasses to human cytomegalovirus","volume":"25","author":"Gilljam","year":"1989","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2018.03.076_b0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2009.09.024","article-title":"Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype","volume":"394","author":"Rodrigo","year":"2009","journal-title":"Virology"},{"issue":"228","key":"10.1016\/j.vaccine.2018.03.076_b0185","doi-asserted-by":"crossref","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1\u2013V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Translat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2018.03.076_b0190","doi-asserted-by":"crossref","first-page":"E1286","DOI":"10.1073\/pnas.1520180113","article-title":"Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets","volume":"113","author":"Ryan","year":"2016","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.076_b0195","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2011.02589.x","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"66","author":"Jutel","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2018.03.076_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.12.057","article-title":"Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine","author":"Hopf","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.076_b0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nature Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.03.076_b0210","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.1002932","article-title":"Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect","volume":"186","author":"Lee","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.03.076_b0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.alit.2017.04.006","article-title":"T follicular helper and TH2 cells in allergic responses","volume":"66","author":"Kubo","year":"2017","journal-title":"Allergol Int: Off J Japanese Soc Allergol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.076_b0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","article-title":"Follicular helper T cells in immunity and systemic autoimmunity","volume":"8","author":"Craft","year":"2012","journal-title":"Nature Rev Rheumatol"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2018.03.076_b0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0091-6749(95)70155-9","article-title":"A reduction in allergen-induced Fc epsilon R2\/CD23 expression on peripheral B cells correlates with successful hyposensitization in grass pollinosis","volume":"95","author":"Jung","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.03.076_b0230","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.1102689","article-title":"Soluble CD23 controls IgE synthesis and homeostasis in human B cells","volume":"188","author":"Cooper","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.076_b0235","article-title":"CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells","author":"Selb","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.03.076_b0240","article-title":"Risk of anaphylaxis after vaccination in children and adults","author":"McNeil","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.03.076_b0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-014-0043-0","article-title":"Vaccination in children with allergy to non active vaccine components","volume":"4","author":"Franceschini","year":"2015","journal-title":"Clin Translat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T08:22:23Z","timestamp":1534926143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18304547"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}